Alexandre Bazinet

BBS1 Mutations in a Wide Spectrum of Phenotypes Ranging From Nonsyndromic Retinitis Pigmentosa to Bardet-Biedl Syndrome

Alejandro Estrada‐Cuzcano, Robert K. Koenekoop, Audrey Sénéćhal et al. · Archives of Ophthalmology · 2012 · 125 citations

Azacitidine plus venetoclax in patients with high-risk myelodysplastic syndromes or chronic myelomonocytic leukaemia: phase 1 results of a single-centre, dose-escalation, dose-expansion, phase 1–2 study

Alexandre Bazinet, Faezeh Darbaniyan, Elias Jabbour et al. · The Lancet Haematology · 2022 · 79 citations

Hematological Malignancy, Medicine, Hematology +7

Prognostic risk signature in patients with acute myeloid leukemia treated with hypomethylating agents and venetoclax

Álex Bataller, Alexandre Bazinet, Courtney D. DiNardo et al. · Blood Advances · 2023 · 72 citations · Full text

Hematological Malignancy, Medicine, Acute Myeloid Leukemia +11

A new ocular phenotype associated with an unexpected but known systemic disorder and mutation: novel use of genomic diagnostics and exome sequencing

Jacek Majewski, S. Al Humaid, Julie Racine et al. · Journal of Medical Genetics · 2011 · 48 citations

Ocular Disease, Mendelian Disorder, Ophthalmology +11

Sustained remissions in CLL after frontline FCR treatment with very-long-term follow-up

Philip A. Thompson, Alexandre Bazinet, William G. Wierda et al. · Blood · 2023 · 42 citations · Full text